Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × Immune Checkpoint Inhibitors × Clear all

NCT07077512 2026-01-21

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05871684 2023-08-01

A Combination Study of CAR-T Therapy in r/r B-NHL

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse